Skip to main content

Advertisement

Log in

The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To determine if statin therapy reduces the incidence of severe sepsis and the levels of inflammatory cytokines in patients with acute bacterial infection.

Design

Double-blind placebo controlled randomized clinical trial.

Setting

Department of medicine and medical intensive care unit in a tertiary university medical center.

Patients and participants

A total of 83 patients with suspected or documented bacterial infection were enrolled. We randomly assigned 42 patients to receive 40 mg of simvastatin orally, followed by 20 mg of simvastatin, and 41 to receive matching placebo.

Measurements and results

The study was prematurely terminated due to slow recruitment rate. Here we report the analysis of the secondary outcome: change in cytokines levels at 72 h. Both groups were evenly matched in terms of co-morbidity and severity of illness on admission. Four of the 83 patients enrolled developed severe sepsis, two in each group. No difference was observed in other clinical variables and there were no mortalities. Cytokine levels were randomly assessed in 40 patients (20 in each group). Both TNF-α and IL-6 levels were significantly reduced in the simvastatin group (p = 0.02 and p = 0.02, respectively), while no such difference was observed in the placebo group (p = 0.35 and 0.39, respectively).

Conclusions

Statin therapy may be associated with a reduction in the levels of inflammatory cytokines in patients with acute bacterial infections. Large controlled trials will determine if this reduction will translate into a clinical benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63:12–23

    Article  PubMed  CAS  Google Scholar 

  2. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG (2007) Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 7:358–368

    Article  PubMed  CAS  Google Scholar 

  3. Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712–1719

    Article  PubMed  CAS  Google Scholar 

  4. Almog Y (2003) Statins, inflammation, and sepsis: hypothesis. Chest 124:740–743

    Article  PubMed  CAS  Google Scholar 

  5. Novack V, Terblanche M, Almog Y (2006) Do statins have a role in preventing or treating sepsis? Crit Care 10:113

    Article  PubMed  Google Scholar 

  6. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A (2004) Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110:880–885

    Article  PubMed  CAS  Google Scholar 

  7. Hackam D, Mamdani M, Li P, Redelmeier D (2006) Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 367:413–418

    Article  PubMed  CAS  Google Scholar 

  8. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H (2007) The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med 35:372–378

    Article  PubMed  CAS  Google Scholar 

  9. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fischer CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  CAS  Google Scholar 

  10. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  11. Panacek E, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C (2004) Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab’)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 32:2173–2182

    PubMed  CAS  Google Scholar 

  12. Alberti C, Brun-Buisson C, Chevret S, Antonalli M, Goodman SV, Martin C, Moreno R, Ochagavia AR, Palazzo M, Werdan K, Le Gall JR (2005) Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 171:461–468

    Article  PubMed  Google Scholar 

  13. Farmer JA (2000) Pleiotropic effects of statins. Curr Atheroscler Rep 2:208–217

    Article  PubMed  CAS  Google Scholar 

  14. Terblanche M, Almog Y, Rosenson R, Smith T, Hackam D (2006) Statins: panacea for sepsis? Lancet Infect Dis 6:242–248

    Article  PubMed  CAS  Google Scholar 

  15. Stoll LL, McCormick ML, Denning GM, Weintraub NL (2004) Antioxidant effects of statins. Drugs Today (Barc) 40:975–990

    Article  CAS  Google Scholar 

  16. Rikitake Y, Liao JK (2005) Rho GTPases, statins, and nitric oxide. Circ Res 97:1232–1235

    Article  PubMed  CAS  Google Scholar 

  17. Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S, Kapiotis S, Woltz M (2004) Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 110:3349–3354

    Article  PubMed  CAS  Google Scholar 

  18. Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, Percevault F, Fruchart JC, Dombrowicz D, Glineur C, Staels B (2006) Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-{alpha} via Inhibition of the Protein Kinase C Signaling Pathway. Circ Res 98:361–369

    Article  PubMed  CAS  Google Scholar 

  19. Almog Y, Terblanche M (2008) Pleiotropic effects of statins: implications for critical care. Contemp Crit Care 5:1–12

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaniv Almog.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 89 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Novack, V., Eisinger, M., Frenkel, A. et al. The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 35, 1255–1260 (2009). https://doi.org/10.1007/s00134-009-1429-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-009-1429-0

Keywords

Navigation